Royal Bank of Canada’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84M | Buy |
86,494
+84,613
| +4,498% | +$1.8M | ﹤0.01% | 3097 |
|
|
2025
Q1 | $36K | Sell |
1,881
-1,918
| -50% | -$36.7K | ﹤0.01% | 5311 |
|
|
2024
Q4 | $68K | Sell |
3,799
-106,135
| -97% | -$1.9M | ﹤0.01% | 5068 |
|
|
2024
Q3 | $2.41M | Buy |
109,934
+93,189
| +557% | +$2.04M | ﹤0.01% | 2521 |
|
|
2024
Q2 | $130K | Buy |
16,745
+5,288
| +46% | +$41.1K | ﹤0.01% | 4716 |
|
|
2024
Q1 | $47K | Sell |
11,457
-21,838
| -66% | -$89.6K | ﹤0.01% | 5129 |
|
|
2023
Q4 | $87K | Buy |
33,295
+13,816
| +71% | +$36.1K | ﹤0.01% | 5172 |
|
|
2023
Q3 | $36K | Buy |
19,479
+7,331
| +60% | +$13.5K | ﹤0.01% | 5462 |
|
|
2023
Q2 | $30K | Buy |
12,148
+11,524
| +1,847% | +$28.5K | ﹤0.01% | 5560 |
|
|
2023
Q1 | $1K | Sell |
624
-1,969
| -76% | -$3.16K | ﹤0.01% | 6540 |
|
|
2022
Q4 | $11K | Buy |
+2,593
| New | +$11K | ﹤0.01% | 6045 |
|
|
2022
Q2 | – | Sell |
-1,620
| Closed | -$4K | – | 7113 |
|
|
2022
Q1 | $4K | Sell |
1,620
-4,226
| -72% | -$10.4K | ﹤0.01% | 6847 |
|
|
2021
Q4 | $15K | Buy |
5,846
+2,536
| +77% | +$6.51K | ﹤0.01% | 6387 |
|
|
2021
Q3 | $17K | Buy |
3,310
+1,771
| +115% | +$9.1K | ﹤0.01% | 6249 |
|
|
2021
Q2 | $11K | Buy |
1,539
+1,518
| +7,229% | +$10.9K | ﹤0.01% | 6338 |
|
|
2021
Q1 | $0 | Buy |
+21
| New | – | ﹤0.01% | 7021 |
|
|
2018
Q4 | – | Sell |
-11,000
| Closed | -$24K | – | 6084 |
|
|
2018
Q3 | $24K | Sell |
11,000
-900
| -8% | -$1.96K | ﹤0.01% | 4982 |
|
|
2018
Q2 | $29K | Hold |
11,900
| – | – | ﹤0.01% | 4810 |
|
|
2018
Q1 | $154K | Buy |
11,900
+9,400
| +376% | +$122K | ﹤0.01% | 3874 |
|
|
2017
Q4 | $28K | Hold |
2,500
| – | – | ﹤0.01% | 4706 |
|
|
2017
Q3 | $31K | Hold |
2,500
| – | – | ﹤0.01% | 4962 |
|
|
2017
Q2 | $28K | Buy |
+2,500
| New | +$28K | ﹤0.01% | 4672 |
|